Cell cycle regulators and their abnormalities in breast cancer
Data up to Jan 2025
Total Citations Per Year
Abstract
References (78)
WAF1, a potential mediator of p53 tumor suppression
1993 • 8,360 citations
The retinoblastoma protein and cell cycle control
1995 • 4,873 citations
A new regulatory motif in cell-cycle control causing specific inhibition of cyclin D/CDK4
1993 • 3,680 citations
Inhibitors of mammalian G1 cyclin-dependent kinases.
1995 • 3,258 citations
A Cell Cycle Regulator Potentially Involved in Genesis of Many Tumor Types
1994 • 2,821 citations
Cyclins and cancer II: Cyclin D and CDK inhibitors come of age
1994 • 2,122 citations
Deletions of the cyclin-dependent kinase-4 inhibitor gene in multiple human cancers
1994 • 1,806 citations
New functional activities for the p21 family of CDK inhibitors.
1997 • 1,414 citations
Inactivation of the CDKN2/p16/MTS1 gene is frequently associated with aberrant DNA methylation in all common human cancers.
1995 • 1,353 citations
Cell cycle control in mammalian cells: role of cyclins, cyclin dependent kinases (CDKs), growth suppressor genes and cyclin-dependent kinase inhibitors (CKIs).
1995 • 1,117 citations
Functional Inactivation of the Retinoblastoma Protein Requires Sequential Modification by at Least Two Distinct Cyclin-cdk Complexes
1998 • 1,058 citations
Increased proteasome-dependent degradation of the cyclin-dependent kinase inhibitor p27 in aggressive colorectal carcinomas
1997 • 1,055 citations
Mammary hyperplasia and carcinoma in MMTV-cyclin D1 transgenic mice
1994 • 982 citations
Translational Control of p27 Kip1 Accumulation During the Cell Cycle
1996 • 864 citations
Decreased levels of the cell-cycle inhibitor p27Kip1 protein: Prognostic implications in primary breast cancer
1997 • 861 citations
CDK-Independent Activation of Estrogen Receptor by Cyclin D1
1997 • 698 citations
Amplification and overexpression of cyclin D1 in breast cancer detected by immunohistochemical staining.
1994 • 673 citations
Differential effects by the p21 CDK inhibitor on PCNA-dependent DNA replication and repair
1994 • 657 citations
Cyclin D1 protein expression and function in human breast cancer
1994 • 515 citations
Arrest of the cell cycle by the tumour-suppressor BRCA1 requires the CDK-inhibitor p21WAF1/CiPl
1997 • 509 citations
PRAD1, a candidate BCL1 oncogene: mapping and expression in centrocytic lymphoma.
1991 • 454 citations
Estrogen-induced Activation of Cdk4 and Cdk2 during G1-S Phase Progression Is Accompanied by Increased Cyclin D1 Expression and Decreased Cyclin-dependent Kinase Inhibitor Association with Cyclin E-Cdk2
1997 • 438 citations
Transcriptional repression of the D-type cyclin-dependent kinase inhibitor p16 by the retinoblastoma susceptibility gene product pRb.
1994 • 370 citations
Molecular cloning and chromosomal mapping of DNA rearranged with the parathyroid hormone gene in a parathyroid adenoma.
1989 • 367 citations
High level expression of p27 kip1 and cyclin D1 in some human breast cancer cells: Inverse correlation between the expression of p27 kip1 and degree of malignancy in human breast and colorectal cancers
1997 • 364 citations
The cell cycle inhibitor p27 is an independent prognostic marker in small (T1a,b) invasive breast carcinomas.
1997 • 354 citations
17beta-Estradiol induces cyclin D1 gene transcription, p36D1-p34cdk4 complex activation and p105Rb phosphorylation during mitogenic stimulation of G(1)-arrested human breast cancer cells.
1996 • 344 citations
p27Kip1: chromosomal mapping to 12p12-12p13.1 and absence of mutations in human tumors.
1995 • 338 citations
Overexpression of cyclin D mRNA distinguishes invasive and in situ breast carcinomas from non-malignant lesions
1995 • 334 citations
Promoting apoptosis: a novel activity associated with the cyclin-dependent kinase inhibitor p27.
1997 • 326 citations
Growth factor, steroid, and steroid antagonist regulation of cyclin gene expression associated with changes in T-47D human breast cancer cell cycle progression.
1993 • 295 citations
DNA tumor virus oncoproteins and retinoblastoma gene mutations share the ability to relieve the cell's requirement for cyclin D1 function in G1.
1994 • 279 citations
Cyclin D1 expression is regulated by the retinoblastoma protein.
1994 • 235 citations
Inactivation of p16 in Human Mammary Epithelial Cells by CpG Island Methylation
1998 • 231 citations
Deregulation of cyclin E in breast cancer.
1995 • 227 citations
Oncogenic activity of cyclin D1 revealed through cooperation with Ha-ras: link between cell cycle control and malignant transformation.
1994 • 219 citations
Determination of the prognostic value of cyclin D1 overexpression in breast cancer.
1995 • 215 citations
Cyclin D1 expression in invasive breast cancer. Correlations and prognostic value.
1997 • 207 citations
Cyclin E overexpression, a negative prognostic factor in breast cancer with strong correlation to oestrogen receptor status
1996 • 198 citations
Amplification of genes within the chromosome 11q13 region is indicative of poor prognosis in patients with operable breast cancer.
1992 • 194 citations
A recombinant adenovirus expressing p27Kip1 induces cell cycle arrest and loss of cyclin-Cdk activity in human breast cancer cells
1997 • 190 citations
A clinicopathological study on overexpression of cyclin D1 and of p53 in a series of 248 patients with operable breast cancer
1996 • 181 citations
Antiestrogen inhibition of cell cycle progression in breast cancer cells in associated with inhibition of cyclin-dependent kinase activity and decreased retinoblastoma protein phosphorylation.
1995 • 179 citations
Amplification of chromosome band 11q13 and a role for cyclin D1 in human breast cancer
1995 • 177 citations
p53, through p21 (WAF1/CIP1), induces cyclin D1 synthesis.
1995 • 155 citations
Deregulation of cyclin E and D1 in breast cancer is associated with inactivation of the retinoblastoma protein
1997 • 150 citations
High frequency of aberrant p16(INK4A) expression in human breast cancer.
1996 • 134 citations
Oncogenic aberrations of p16INK4/CDKN2 and cyclin D1 cooperate to deregulate G1 control.
1995 • 129 citations
Cyclin D1 (PRAD1) protein expression in breast cancer: approximately one-third of infiltrating mammary carcinomas show overexpression of the cyclin D1 oncogene.
1995 • 127 citations
Immunohistochemistry of Cyclin D1 in Human Breast Cancer
1994 • 125 citations
Cyclin E, a redundant cyclin in breast cancer
1996 • 121 citations
p21WAF1 immunohistochemical expression in breast carcinoma: correlations with clinicopathological data, oestrogen receptor status, MIB1 expression, p53 gene and protein alterations and relapse-free survival
1996 • 121 citations
p21/waf1/cip1 and mdm-2 expression in breast carcinoma patients as related to prognosis
1997 • 119 citations
The retinoblastoma gene in breast cancer: allele loss is not correlated with loss of gene protein expression.
1992 • 113 citations
Retinoblastoma and p16 proteins in mammary carcinoma: Their relationship to cyclin D1 and histopathological parameters
1998 • 112 citations
Cyclin D1 as a cellular proto-oncogene
1995 • 111 citations
p21/WAF1/CIP1 EXPRESSION IN NORMAL MUCOSA AND IN ADENOMAS AND ADENOCARCINOMAS OF THE COLON: ITS RELATIONSHIP WITH DIFFERENTIATION
1996 • 110 citations
Mutational analysis of CDKN2 (MTS1/p16ink4) in human breast carcinomas.
1994 • 107 citations
How viral oncogenes make the cell cycle
1996 • 89 citations
Mutational analysis of the human cyclin-dependent kinase inhibitor p27kip1 in primary breast carcinomas
1996 • 86 citations
Amplification of CCND1 and expression of its protein product, cyclin D1, in ductal carcinoma in situ of the breast.
1997 • 84 citations
Chromosome 11q13 abnormalities in human breast cancer.
1993 • 82 citations
CYCLIN D1 AND RETINOBLASTOMA GENE EXPRESSION IN HUMAN BREAST CARCINOMA: CORRELATION WITH TUMOUR PROLIFERATION AND OESTROGEN RECEPTOR STATUS
1997 • 78 citations
Cyclin D1 and associated proteins in mammary ductal carcinomain situ and atypical ductal hyperplasia
1998 • 76 citations
Growth Factor, Steroid, and Steroid Antagonist Regulation of Cyclin Gene Expression Associated With Changes in T-47D Human Breast Cancer Cell Cycle Progression
1993 • 74 citations
Expression of the cyclin‐dependent kinase inhibitors p16INK4, p15INK4B and p21Waf1/cip1 in human breast cancer
1995 • 71 citations
Overexpression of cyclin E in the HC11 mouse mammary epithelial cell line is associated with growth inhibition and increased expression of p27(Kip1).
1996 • 60 citations
Clinical significance of cyclin D1 expression in patients with node-positive breast carcinoma treated with adjuvant therapy
1996 • 60 citations
Retinoblastoma and p53 gene product expression in breast carcinoma: Immunohistochemical analysis and clinicopathologic correlation
1992 • 59 citations
p21WAF1/Cip1 is associated with cyclin D1CCND1 expression and tubular differentiation but is independent of p53 overexpression in human breast carcinoma
1998 • 55 citations
p21WAF1/Cip1 expression is associated with cell differentiation but not with p53 mutations in squamous cell carcinomas of the larynx
1997 • 51 citations
Hypomethylation and increased gene expression of p16INK4a in primary and metastatic breast carcinoma as compared to normal breast tissue
1998 • 47 citations
The cell cycle in breast cancer
1997 • 47 citations
Cyclin gene expression and growth control in normal and neoplastic human breast epithelium
1993 • 44 citations
Constitutive overexpression of cyclin D1 does not prevent inhibition of hormone-responsive human breast cancer cell growth by antiestrogens.
1998 • 34 citations
Cyclin D1 amplification and expression in human breast carcinoma: correlation with histological prognostic markers and oestrogen receptor expression
1996 • 22 citations
Analysis of phosphorylation of pRB and its regulatory proteins in breast cancer.
1997 • 20 citations
Absence of p16 gene (CDKN2) deletions in microdissected primary breast carcinoma specimens
1997 • 6 citations